Results 131 to 140 of about 664,449 (349)

ACCESSIBLE TOURISM – THE IGNORED OPPORTUNITY [PDF]

open access: yes
To create a positive visitor experience, a key factor in obtaining economic benefits, the tourism industry must pay attention to all the elements that contribute to it, especially to accessibility.
Souca Maria Luiza
core  

All that jazz! Festival-specific predictors of service quality, satisfaction and repurchase intentions' [PDF]

open access: yes, 2005
[Abstract]: With growing consensus that performance-only constructs may serve as better predictors of service quality (SQ) than the original SERVQUAL scale, this research developed a FESTPERF instrument to investigate the questions of: whether the SQ ...
Stokes, Robyn, Tkaczynski, Aaron
core  

Vestibular Patient Journey: Insights From Vestibular Disorders Association (VeDA) Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Vestibular symptoms impose a high burden of disability. Understanding real‐world diagnostic and treatment pathways can identify care gaps and guide interventions. We aimed to characterize symptom profiles, diagnostic trends, provider involvement, and treatment patterns in vestibular disorders.
Ali Rafati   +10 more
wiley   +1 more source

Study of Economic Impacts Derived from 2005 to 2009 Rural Texas Community Events and Factors that Predict Spending? [PDF]

open access: yes
In this paper, we review the tourism impact from state supported events associated with Texas Rural Economic Development program and in the process of funding measure aspects of events that are found to be related to economic value.
Hanagriff, Roger D.   +2 more
core   +1 more source

Could guns and rain spell the end for the Karamojong? [PDF]

open access: yes, 2010
Over one million people live in Karamoja, a region found in the north Eastern part of Uganda. To a visitor passing through from the capital city Kampala, Karamoja may look like any other region in Uganda but appearances can be deceptive.
Ferloni, Mark   +3 more
core  

Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cognitive decline is a disabling and variable feature of Parkinson disease (PD). While cholinergic system degeneration is linked to cognitive impairments in PD, most prior research reported cross‐sectional associations. We aimed to fill this gap by investigating whether baseline regional cerebral vesicular acetylcholine transporter ...
Taylor Brown   +6 more
wiley   +1 more source

Posterior Cortical Atrophy in the Asia‐Pacific: A Report From the PCA Asian Workgroup

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Posterior Cortical Atrophy (PCA) is a distinct dementia syndrome primarily affecting spatial abilities and visual processing. It is associated with degeneration in the posterior part of the brain. PCA is subclassified into PCA‐pure and PCA‐plus syndromes based on consensus criteria.
Yuttachai Likitjaroen   +11 more
wiley   +1 more source

Using grounded theory approach: theoretical and practical issues in modelling heritage visitor experience [PDF]

open access: yes, 2004
Purpose ? The purpose of this paper is to present grounded theory as an alternative approach for conceptualizing and modelling the consumer experience.
Daengbuppha, Jaruwan   +2 more
core  

Sex Representation in US Stroke Clinical Trials: A Decade of Trends and Challenges

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Stroke remains a major cause of disability and mortality in the US, with significant sex‐based disparities, and females remain underrepresented in stroke clinical trials. We aimed to examine sex representation in US‐based stroke clinical trials, identify trial characteristics associated with higher female enrollment (≥ 50%), and ...
Chaitali Dagli   +5 more
wiley   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy